Get the Weekly Intelligence Brief — top committee picks every Sunday.
ESTA · NASDAQ · STOCK

Establishment Labs Holdings (ESTA) Stock Analysis

Healthcare Updated October 14, 2026
$61.44
52W $44.22 – $97.59
52/100
$1.72B
-44.7
1.06
AI Committee Verdict
Watch
52/100
Conviction: Contested · 50% agreement · 6 analysts
+35.0%
-7.1%
4.94:1
Contested

Is ESTA Bullish or Bearish?

Mixed. Innellis AI committee rates Establishment Labs Holdings Inc. (ESTA) Watch with a composite score of 52/100 , based on 6 analysts with 50% agreement. Last updated October 14, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +8.33 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -11.67 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 38.5% yoy -- genuine top-line momentum. Value Analyst remains cautious — price-to-book of 89.9x prices in significant intangible value. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • Revenue growing 38.5% YoY -- genuine top-line momentum — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
  • Price-to-book of 89.9x prices in significant intangible value — Value
  • ROE of only -203.9% -- cheap may mean cheap for a reason — Value
  • Debt-to-equity of 11.04 adds balance-sheet risk to the value case — Value
  • RSI at 25 is in oversold territory (could mean either capitulation or a bounce setup) — Technical
  • MACD histogram negative -- bearish momentum — Technical
  • Price trading below the lower Bollinger Band -- stretched to the downside — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 14, 2026
Overall Committee Score
52/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 89%
of 192 Healthcare peers
Value Analyst bearish
32 / 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− Price-to-book of 89.9x prices in significant intangible value
Growth Analyst bullish
85 / 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ Revenue growing 38.5% YoY -- genuine top-line momentum
Technical Analyst bearish
38 / 100 · High confidence
Price action is deteriorating -- trend and/or momentum are working against this name
− RSI at 25 is in oversold territory (could mean either capitulation or a bounce setup)
Risk Analyst bearish
32 / 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 11.04) amplifies downside in a stress scenario
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst neutral
58 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager bearish
35 / 100 · Low confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− 2 existing position pair(s) are highly correlated already
Open Full Terminal →

Investment Thesis Evolution

Committee score weakened from 55.8 to 51.7.

Analyst-level changes:
  • Macro Analyst: score 80->65 (-15).
  • Portfolio Manager: score 30->35 (+5).
  • Risk Analyst: +1 bearish signal(s).
  • Technical Analyst: stance neutral->bearish; score 48->38 (-10); +3 bearish signal(s).

Comparing 2026-10-13 to 2026-10-14 (1 day apart).

Technical Analysis

RSI (14)
23.1
Oversold
MACD Histogram
-0.344
Bearish Momentum
Trend Direction
Downtrend
Weekly: Uptrend
Market Structure
Lh Ll
Support
$53.66
Resistance
$78.00
Bollinger %B
0.01
Inside Bands
Price vs Moving Averages
EMA 9
$61.42 Above
EMA 21
$64.55 Below
EMA 50
$69.84 Below
EMA 200
$70.13 Below

Fundamental Analysis

Valuation
67
Growth
72
Profitability
25
Financial Health
50
Cash Flow
15
Valuation
P/E Ratio -44.7×
P/B Ratio 81.48×
PEG Ratio -0.50
Dividend Yield 0.00%
52W High $97.59
52W Low $44.22
Quality & Growth
ROE -21686.0%
ROA -1429.7%
Gross Margin 7048.9%
Operating Margin -763.0%
Revenue Growth YoY —
Debt / Equity 12.20
AI Fundamental Assessment
P/E ratio of -44.7 (inexpensive relative to a 15-40x range); Price-to-book of 81.5x; PEG ratio of -0.5 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -216.9%; Return on assets of -14.3%; Net margin of -15.8%; Gross margin of 70.5%; Current ratio of 3.84 (healthy short-term liquidity); Debt-to-equity of 12.20; Free cash flow per share is negative (-1.40); Most recent quarter beat estimates by 3.8%; EPS growth accelerating (-400.0% -> +26.7% QoQ); Analyst estimates falling over recent quarters
Get the Full ESTA Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime